AI Article Synopsis
- The study investigates how a specific Y1 receptor ligand works together with a P-glycoprotein inhibitor to enhance the treatment effectiveness for multidrug-resistant breast cancer.
- The combination targets mechanisms that cancer cells use to survive against multiple drugs, potentially improving patient outcomes.
- The research findings suggest that this synergistic approach could be a promising strategy for overcoming drug resistance in cancer treatment.
Article Abstract
Correction for 'A Y1 receptor ligand synergized with a P-glycoprotein inhibitor improves the therapeutic efficacy of multidrug resistant breast cancer' by Yinjie Wang , , 2019, , 4748-4757, https://doi.org/10.1039/C9BM00337A.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/d4bm90022g | DOI Listing |
Publication Analysis
Top Keywords
correction receptor
8
receptor ligand
8
ligand synergized
8
synergized p-glycoprotein
8
p-glycoprotein inhibitor
8
inhibitor improves
8
improves therapeutic
8
therapeutic efficacy
8
efficacy multidrug
8
multidrug resistant
8
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!